Annabel Samimy
Stock Analyst at Stifel
(3.38)
# 852
Out of 4,827 analysts
56
Total ratings
41.67%
Success rate
26.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Annabel Samimy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Initiates: Buy | $143 | $102.20 | +39.93% | 1 | Apr 10, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $22.44 | +100.53% | 1 | Mar 26, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $50 | $26.50 | +88.68% | 1 | Jan 8, 2025 | |
| ALT Altimmune | Initiates: Buy | $18 | $5.43 | +231.49% | 1 | Jan 8, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $17 | $3.60 | +372.22% | 4 | Nov 22, 2024 | |
| MBX MBX Biosciences | Initiates: Buy | $40 | $10.79 | +270.71% | 1 | Oct 8, 2024 | |
| KMDA Kamada | Initiates: Buy | $18 | $7.04 | +155.68% | 1 | Jul 3, 2024 | |
| PHAT Phathom Pharmaceuticals | Initiates: Buy | $24 | $2.31 | +938.96% | 1 | May 3, 2024 | |
| RGNX REGENXBIO | Maintains: Buy | $40 | $6.98 | +473.07% | 2 | Apr 12, 2024 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $80 | $27.49 | +191.01% | 6 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $230 | $99.89 | +130.26% | 8 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 → $25 | $10.45 | +139.23% | 1 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $18.61 | +88.07% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $65 | $18.10 | +259.12% | 3 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $28 → $11 | $0.32 | +3,324.66% | 4 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $14.84 | +203.34% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $0.85 | +846.19% | 1 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.76 | +3,053.33% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $20 | $29.35 | -31.86% | 1 | Apr 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $750 | $1.41 | +53,095.26% | 3 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $24 | $31.07 | -22.76% | 7 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $21 | $0.61 | +3,343.75% | 6 | Sep 18, 2019 |
Ligand Pharmaceuticals
Apr 10, 2025
Initiates: Buy
Price Target: $143
Current: $102.20
Upside: +39.93%
Palvella Therapeutics
Mar 26, 2025
Initiates: Buy
Price Target: $45
Current: $22.44
Upside: +100.53%
Structure Therapeutics
Jan 8, 2025
Initiates: Buy
Price Target: $50
Current: $26.50
Upside: +88.68%
Altimmune
Jan 8, 2025
Initiates: Buy
Price Target: $18
Current: $5.43
Upside: +231.49%
Inventiva
Nov 22, 2024
Maintains: Buy
Price Target: $20 → $17
Current: $3.60
Upside: +372.22%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $40
Current: $10.79
Upside: +270.71%
Kamada
Jul 3, 2024
Initiates: Buy
Price Target: $18
Current: $7.04
Upside: +155.68%
Phathom Pharmaceuticals
May 3, 2024
Initiates: Buy
Price Target: $24
Current: $2.31
Upside: +938.96%
REGENXBIO
Apr 12, 2024
Maintains: Buy
Price Target: $40
Current: $6.98
Upside: +473.07%
Viking Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $80
Current: $27.49
Upside: +191.01%
Mar 15, 2024
Maintains: Buy
Price Target: $225 → $230
Current: $99.89
Upside: +130.26%
Mar 8, 2024
Reiterates: Buy
Price Target: $23 → $25
Current: $10.45
Upside: +139.23%
Oct 5, 2023
Initiates: Buy
Price Target: $35
Current: $18.61
Upside: +88.07%
Aug 29, 2023
Maintains: Buy
Price Target: $60 → $65
Current: $18.10
Upside: +259.12%
Jun 26, 2023
Downgrades: Hold
Price Target: $28 → $11
Current: $0.32
Upside: +3,324.66%
Mar 7, 2023
Initiates: Buy
Price Target: $45
Current: $14.84
Upside: +203.34%
Nov 10, 2022
Upgrades: Buy
Price Target: $8
Current: $0.85
Upside: +846.19%
Aug 24, 2021
Initiates: Buy
Price Target: $24
Current: $0.76
Upside: +3,053.33%
Apr 24, 2020
Initiates: Hold
Price Target: $20
Current: $29.35
Upside: -31.86%
Apr 16, 2020
Maintains: Buy
Price Target: $700 → $750
Current: $1.41
Upside: +53,095.26%
Apr 16, 2020
Maintains: Hold
Price Target: $25 → $24
Current: $31.07
Upside: -22.76%
Sep 18, 2019
Maintains: Hold
Price Target: $15 → $21
Current: $0.61
Upside: +3,343.75%